Publication Name	World Journal of Hepatology
Manuscript ID	96760
Country	India

Received	2024-05-14 13:58
Peer-Review Started	2024-05-14 13:58
To Make the First Decision
Return for Revision	2024-08-15 20:57
Revised	2024-08-25 12:01
Second Decision	2024-09-02 02:41
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-09-02 08:51
Articles in Press	2024-09-02 08:51
Publication Fee Transferred
Edit the Manuscript by Language Editor	2024-09-03 15:00
Typeset the Manuscript	2024-09-05 09:21
Publish the Manuscript Online	2024-09-23 10:30

ISSN	1948-5182 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Editorial
Article Title	Functional cure of chronic hepatitis B-hope or hype?
Manuscript Source	Invited Manuscript
All Author List	Gautam Ray
ORCID	Author(s) ORCID Number Gautam Ray http://orcid.org/0000-0003-4859-8729
Funding Agency and Grant Number
Corresponding Author	Gautam Ray, Visiting Professor, MD, Director, Director, Department of Gastroenterology Unit, Department of Medicine, B.R.Singh Hospital, Sealdah, Kolkata 700014, West Bengal, India. gautam1910@yahoo.com
Key Words	Hepatitis B; Drugs; Clinical trial; Therapy; Novel therapies; Functional cure
Core Tip	Due to underperformance of the World Health Organization policy of 2016 to eliminate hepatitis B by 2030, the disease burden remains substantial and there is unmet need for newer curative therapies due to the inability of the presently approved therapies to completely eradicate the virus. Many novel molecules are in Phase I/II trial but only a few have shown preliminary encouraging results only in combination with pegylated interferon and/or nucleos(t)ide analogues with risk of adverse events. Since drug development will be a lengthy process, the present emphasis should still be on improving the preventive measures like vaccination, increasing diagnosis and linkage to care.
Publish Date	2024-09-23 10:30
Citation	<p>Ray G. Functional cure of chronic hepatitis B-hope or hype? <i>World J Hepatol</i> 2024; 16(9): 1199-1205</p>
URL	https://www.wjgnet.com/1948-5182/full/v16/i9/1199.htm
DOI	https://dx.doi.org/10.4254/wjh.v16.i9.1199

Full Article (PDF)	WJH-16-1199-with-cover.pdf
Manuscript File	96760_Auto_Edited_005006.docx
Answering Reviewers	96760-answering-reviewers.pdf
Audio Core Tip	96760-audio.m4a
Conflict-of-Interest Disclosure Form	96760-conflict-of-interest-statement.pdf
Copyright License Agreement	96760-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	96760-non-native-speakers.pdf
Peer-review Report	96760-peer-reviews.pdf
Scientific Misconduct Check	96760-scientific-misconduct-check.png
Scientific Editor Work List	96760-scientific-editor-work-list.pdf
CrossCheck Report	96760-crosscheck-report.pdf